These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Atypical skin conditions of the neck and back as a dermal manifestation of anti-HMGCR antibody-positive myopathy. Kurashige T; Nakamura R; Murao T; Mine N; Sato M; Katsumata R; Kanaya Y; Dodo Y; Sugiura T; Ohshita T BMC Immunol; 2024 May; 25(1):30. PubMed ID: 38734636 [TBL] [Abstract][Full Text] [Related]
3. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697 [TBL] [Abstract][Full Text] [Related]
5. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience. Klein M; Mann H; Pleštilová L; Zámečník J; Betteridge Z; McHugh N; Vencovský J Rheumatology (Oxford); 2015 Nov; 54(11):2010-4. PubMed ID: 26109604 [TBL] [Abstract][Full Text] [Related]
6. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China. Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933 [TBL] [Abstract][Full Text] [Related]
7. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan. Watanabe Y; Suzuki S; Nishimura H; Murata KY; Kurashige T; Ikawa M; Asahi M; Konishi H; Mitsuma S; Kawabata S; Suzuki N; Nishino I Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171 [TBL] [Abstract][Full Text] [Related]
8. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins. Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224 [TBL] [Abstract][Full Text] [Related]
13. [Clinical and pathological characteristics of immune mediated necrotizing myopathy]. Yang HX; Tian XL; Jiang W; Li WL; Liu QY; Peng QL; Wang GC; Lu X Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):989-995. PubMed ID: 31848492 [TBL] [Abstract][Full Text] [Related]
14. Bergua C; Chiavelli H; Allenbach Y; Arouche-Delaperche L; Arnoult C; Bourdenet G; Jean L; Zoubairi R; Guerout N; Mahler M; Benveniste O; Drouot L; Boyer O Ann Rheum Dis; 2019 Jan; 78(1):131-139. PubMed ID: 30309969 [TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy. Limaye V; Bundell C; Hollingsworth P; Rojana-Udomsart A; Mastaglia F; Blumbergs P; Lester S Muscle Nerve; 2015 Aug; 52(2):196-203. PubMed ID: 25521389 [TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies. Ge Y; Lu X; Peng Q; Shu X; Wang G PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687 [TBL] [Abstract][Full Text] [Related]
18. Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble. Tanboon J; Sanmaneechai O; Charuvanij S; Sangruchi T; Galindo-Feria AS; Lundberg IE; Ohnuki Y; Shiina T; Suzuki S; Nishino I Neuromuscul Disord; 2019 Jul; 29(7):543-548. PubMed ID: 31204143 [TBL] [Abstract][Full Text] [Related]
19. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies. Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107 [TBL] [Abstract][Full Text] [Related]
20. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed. Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]